Thomas Bendall

All views my own | Product Strategy & Access Director | HTA, Reimbursement & HEOR | Strategic Planning | Access & Evidence | Pharmaceutical New Product Development & Positioning | Ambitious About Neurodiversity

View articles by Thomas Bendall

The Longevity Imperative - building a better…

January 16, 2025

12 likes6 comments

What is Real-World Data and Real-World…

September 11, 2024

10 likes

What is heterogeneity?

August 8, 2024

5 likes

What is uncertainty?

July 30, 2024

12 likes7 comments

What is a budget impact analysis?

July 3, 2024

10 likes

What is a cost-benefit analysis?

June 26, 2024

6 likes

What is a cost-minimisation analysis?

June 19, 2024

13 likes3 comments

What is the difference between…

June 12, 2024

9 likes

What are Disability Adjusted Life Years or…

June 5, 2024

7 likes

What are QALYs or Quality Adjusted Life…

May 28, 2024

12 likes

What are health state utilities?

May 21, 2024

3 likes

Health equity, public health and associated…

May 16, 2024

9 likes

What is economic evaluation?

May 14, 2024

5 likes

What is a decision problem?

May 7, 2024

14 likes

What is health?

April 2, 2024

17 likes3 comments

What is meta-analysis?

March 26, 2024

7 likes

What is systematic review?

March 19, 2024

19 likes

Multiattribute utility theory

March 14, 2024

6 likes2 comments

What are HTA processes & methods?

March 12, 2024

8 likes2 comments

What is HTA/Health Technology Assessment?

March 6, 2024

18 likes